Drug Resistance - Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
Arthritis - Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Chronic Pain - Cephalon Submits Supplemental New Drug Application for FENTORA
Bioterrorism - Findings from University of North Carolina in bioterrorism reported
Bioterrorism - Research on bioterrorism published by B. Budowle et al
Escherichia Coli - Findings from University of Sao Paulo provide new insights into Escherichia coli
Escherichia Coli - Research from University of Leon in Escherichia coli provides new insights
Escherichia Coli - Researchers from Texas A&M University describe findings in Escherichia coli
Hemorrhagic Fever - New hemorrhagic fever research has been reported by M.A. Cevik et al
Hemorrhagic Fever - New hemorrhagic fever research has been reported by scientists at National Institutes of Health
Legionnaire Disease - Researchers at University of Sao Paulo, Medical Department have published new data on legionnaire disease
Plague - Researchers from University of Kentucky discuss findings in plague
West Nile Virus - Data on west nile virus described by N. Jain et al
Anthrax Genetics - Researchers from Centers for Disease Control and Prevention publish findings in anthrax genetics
Hantavirus Genetics - Studies from Korea University, Department of Microbiology yield new data on hantavirus genetics
Hantavirus Therapy - Studies from Johns Hopkins University have provided new data on hantavirus therapy
Angioneurotic Edema - Lev Presents Significant Data from Pivotal Phase III Trial of Cinryze(TM) in Acute Treatment of Hereditary Angioedema at ACAAI Meeting
Anthrax - Russian Cold War Era Immune Biotechnology Gives Retired Pharmacist Second Career
Biotechnology - tohamed Skin Stapler: Wound Closure With Perfect Results
Cancer - Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Chronic Kidney Failure - FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
HIV/AIDS - Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Leukemia - INNOVIVE Pharmaceuticals Initiates Pivotal Phase II Clinical Trial with Tamibarotene
Neuroscience - Northstar Neuroscience Announces Updated Timeline for EVEREST Pivotal Trial Data Analysis and Planned PMA Submission
Prostate Cancer - Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
Regulatory Actions - NCPA President Steve Giroux to Speak at FDA Behind the Counter Hearing
Terrorism - America Faces High Risk of a Terrorist Anthrax Attack; Six Years After 2001 Anthrax Incidents U.S. Still Largely Unprepared Warns Terrorism Expert Neil Livingstone
Vaccine Safety - FDA petition would protect public from dangerous drugs
